| 000 | 01646 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515173013.0 | ||
| 264 | 0 | _c20090910 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1462-0332 | ||
| 024 | 7 |
_a10.1093/rheumatology/kep122 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorneff, Gerd | |
| 245 | 0 | 0 |
_aSafety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cAug 2009 |
||
| 300 |
_a916-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Juvenile _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aEbert, Annette | |
| 700 | 1 | _aFitter, Sigrid | |
| 700 | 1 | _aMinden, Kirsten | |
| 700 | 1 | _aFoeldvari, Ivan | |
| 700 | 1 | _aKümmerle-Deschner, Jasmin | |
| 700 | 1 | _aThon, Angelika | |
| 700 | 1 | _aGirschick, Herrmann J | |
| 700 | 1 | _aWeller, Frank | |
| 700 | 1 | _aHuppertz, Hans I | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 48 _gno. 8 _gp. 916-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kep122 _zAvailable from publisher's website |
| 999 |
_c18908047 _d18908047 |
||